scispace - formally typeset
M

Masaki Tokunaga

Researcher at National Institute of Radiological Sciences

Publications -  29
Citations -  546

Masaki Tokunaga is an academic researcher from National Institute of Radiological Sciences. The author has contributed to research in topics: Radioligand & AMPA receptor. The author has an hindex of 15, co-authored 29 publications receiving 439 citations.

Papers
More filters
Journal ArticleDOI

In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.

TL;DR: The time-course of the [11C]PBB3- and TSPO-PET finding suggests that tau deposition triggers progressive neuroinflammation, and the sequential changes can be evaluated in vivo in mouse brains.
Journal ArticleDOI

Neuroimaging and Physiological Evidence for Involvement of Glutamatergic Transmission in Regulation of the Striatal Dopaminergic System

TL;DR: The pharmacological reversal of methamphetamine-stimulated dopaminergic overflow by suppression of group I metabotropic glutamate (mGlu) receptor in living primates and rodents is demonstrated and insights on dopamine–glutamate cross talk are extended from extrastriatal localization of responsible mGlu receptors to intrastRIatal synergy.
Journal ArticleDOI

Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.

TL;DR: The findings indicate that tau-induced disruption of the inhibitory synapse may be a critical trigger of progressive neurodegeneration, resulting in massive neuronal loss, and PET assessments of inhibitory versus excitatory synapses potentially offer in vivo indices for hyperexcitability and excitotoxicity early in the etiologic pathway of neurodegnerative tauopathies.
Journal ArticleDOI

Quantification of central substance P receptor occupancy by aprepitant using small animal positron emission tomography.

TL;DR: Findings support the utility of small animals and quantitative PET in the development of drugs targeting NK-1 receptors and the validity of this in vivo imaging system for preclinical characterization of candidate agents acting on NK- 1 receptors.